Aplex Bio

Aplex Bio is at the forefront of advanced molecular testing, delivering platform technologies that expand capabilities in precision genomics, molecular diagnostics, and high-frequency biological screening. Hyperplex PCR™, the company’s next-generation platform, introduces a new paradigm in molecular measurement by combining multiplexed detection, molecular counting, and single-nucleotide discrimination in a single workflow. The platform delivers digital-like single-copy sensitivity while scaling to 100+ targets per well, addressing limitations in plex, precision, and cost-efficiency that constrain both traditional PCR and sequencing technologies. Aplex Bio is dedicated to advancing the next generation of molecular diagnostics and enabling technologies for population-scale applications that can contribute to improved healthcare outcomes worldwide. The company is headquartered in Stockholm, Sweden.

To push the boundaries of molecular analysis, enabling impactful knowledge-based decisions in healthcare and sustainability without compromise.